Table 2.
Comparison of variables between the PA and control groups in patients with IgAN.
|
Enrollment |
After completing training program |
|||||
|---|---|---|---|---|---|---|
| PA group (n=108) | Control group (n=108) | P value | PA group (n=108) | Control group (n=108) | P value | |
| Spiroergometric study | ||||||
| HRresting (beats/minute) | 78.1 ± 9.7 | 80.1 ± 8.7 | 0.11 | 72.6 ± 7.5 | 82.1 ± 9.8 | <0.001 |
| sBPresting (mmHg) | 145.2 ± 15.2 | 142.8 ± 12.3 | 0.18 | 132.3 ± 10.9 | 145.8 ± 14.9 | <0.001 |
| dBPresting (mmHg) | 89.8 ± 7.3 | 90.4 ± 5.1 | 0.48 | 76.5 ± 6.9 | 91.2 ± 4.9 | <0.001 |
| PAT (minute) | 32.5 ± 12.3 | 31.6 ± 14.7 | 0.67 | 73.2 ± 12.7 | 31.1 ± 15.2 | <0.001 |
| METs | 10.4 ± 1.8 | 10.7 ± 1.6 | 0.20 | 12.4 ± 2.6 | 11.2 ± 1.5 | <0.001 |
| HRmax (beats/minute) | 140.1 ± 20.1 | 140.5 ± 18.9 | 0.88 | 138.8 ± 17.1 | 149.6 ± 18.4 | <0.001 |
| sBPmax (mmHg) | 197.3 ± 18.6 | 193.1 ± 16.4 | 0.08 | 179.1 ± 20.7 | 180.0 ± 18.5 | 0.74 |
| dBPmax (mmHg) | 89.6 ± 8.1 | 89.3 ± 6.8 | 0.77 | 80.1 ± 9.7 | 82.1 ± 7.8 | 0.09 |
| Double product | 25.3 ± 5.6 | 26.1 ± 4.5 | 0.25 | 21.6 ± 5.1 | 27.1 ± 4.1 | <0.001 |
| PVEmax (L/minute) | 40.3 ± 11.6 | 39.6 ± 11.9 | 0.44 | 60.1 ± 15.6 | 37.3 ± 14.1 | <0.001 |
| VO2peak (mL/kg/minute) | 19.4 ± 5.9 | 20.1 ± 4.6 | 0.33 | 27.7 ± 6.1 | 20.2 ± 4.1 | <0.001 |
| BDI-II scores | ||||||
| Mildly depressed | 16.6 ± 2.1 | 16.4 ± 1.9 | 0.46 | 14.1 ± 1.2 | 16.3 ± 1.7 | <0.001 |
| Moderately depressed | 25.2 ± 2.6 | 24.9 ± 2.3 | 0.37 | 21.0 ± 1.6 | 25.1 ± 2.5 | <0.001 |
| Severely depressed | 48.2 ± 11.3 | 49.1 ± 9.8 | 0.53 | 33.4 ± 9.6 | 46.1 ± 10.1 | <0.001 |
| EPQ scores | ||||||
| Psychoticism | 7.2 ± 1.6 | 6.9 ± 1.5 | 0.16 | 5.6 ± 0.8 | 7.2 ± 0.9 | <0.001 |
| Neuroticism | 12.1 ± 2.4 | 12.3 ± 1.9 | 0.50 | 9.1 ± 1.8 | 11.9 ± 1.2 | <0.001 |
| Extroversion | 9.8 ± 1.7 | 10.1 ± 1.6 | 0.18 | 7.8 ± 1.5 | 9.7 ± 0.9 | <0.001 |
| Lies | 11.7 ± 1.3 | 11.5 ± 1.2 | 0.24 | 8.2 ± 1.0 | 11.7 ± 1.2 | <0.001 |
| HRQL scores | ||||||
| QLI | 7.2 ± 1.6 | 7.3 ± 1.8 | 0.67 | 9.6 ± 1.5 | 8.9 ± 1.8 | 0.002 |
| SF-36 PCS | 41.6 ± 7.2 | 39.9 ± 6.8 | 0.08 | 47.5 ± 8.7 | 44.6 ± 7.1 | 0.007 |
| SF-36 MCS | 45.1 ± 9.1 | 44.7 ± 7.9 | 0.73 | 49.6 ± 9.8 | 43.7 ± 7.7 | <0.001 |
| LSI | 40.6 ± 8.5 | 41.1 ± 9.7 | 0.69 | 56.1 ± 9.7 | 47.1 ± 8.7 | 0.001 |
Note: Values are median ± standard deviation.
Abbreviations: IgAN, IgA nephropathy; PA, physical activity; HR, heart rate; sBP, systolic blood pressure; dBP, diastolic blood pressure; PAT, physical activity time; METs, metabolic equivalents; PVEmax, maximum pulmonary ventilation; VO2peak, peak oxygen uptake; BDI-II, Beck Depression Inventory-II; EPQ, Eysenck Personality Questionnaire; HRQL, health-related quality of life; QLI, Quality of Life Index; SF-36 PCS, Short Form-36 Physical Component Scale; SF-36 MCS, SF-36 Mental Component Scale; LSI, Life Satisfaction Index.